The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJIT.L Regulatory News (AJIT)

  • There is currently no data for AJIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of First General Meeting & AGM

29 Sep 2023 07:00

RNS Number : 0657O
abrdn Japan Investment Trust plc
29 September 2023
 

29 September 2023

LEI: 5493007LN438OBLNLM64

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL.

 

The information communicated in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this information is considered to be in the public domain.

 

ABRDN JAPAN INVESTMENT TRUST PLC (the "Company" or "AJIT")

 

Results of First General Meeting and Annual General Meeting

 

 

Results of First General Meeting and Annual General Meeting

 

In connection with the proposals for the voluntary winding up of the Company and combination with Nippon Active Value Fund plc ("NAVF") by means of a scheme of reconstruction and winding up of the Company under section 110 of the Insolvency Act 1986 (the "Scheme"), the Board is pleased to announce that the special resolutions, which were put forward at the First General Meeting, and the ordinary and special resolutions put forward at the Annual General Meeting, both held today, have been approved by Shareholders. Please note that of the resolutions numbered 1 to 12 presented at the Annual General Meeting, numbers 11 and 12 were special resolutions.

 

As set out in the circular to shareholders dated 1 September 2023 (the "Circular"), as a result of the passing of the first special resolution at the First General Meeting, the Company's articles of associations were amended to remove the continuation vote provisions therein and therefore the Company was not required to put Resolution 13 to shareholders at the Annual General Meeting.

 

Details of the number of proxy votes cast for, against and withheld in respect of the resolutions are set out below and will also be published on the Company's website: abrdnjapan.co.uk.

 

Resolutions Presented at the First General Meeting

 

 

 

For (inc Discretionary)

Against

Abstained

Total

Resolution

Votes

%

Votes

%

Votes

%

 

1

Reclassification of the shares in issue as shares with "A" rights or shares with "B" rights as the case may be in accordance with the terms of the Scheme and amendment of the Company's articles of association to give effect to the Scheme

 

6,182,834

99.96

2,226

0.04

2,622

0.04

6,185,060

2

Subject to the successful passing of resolution 1: the voluntary winding-up of the Company and the appointment of Liquidators, and amendment of the Articles of Association

6,183,489

 

 

 

99.96

2,768

0.04

1,311

0.02

6,186,257

 

 

 

 

 

Resolutions Presented at the Annual General Meeting

 

 

 

For (inc Discretionary)

Against

Abstained

Total

Resolution

Votes

%

Votes

%

Votes

%

 

1

To receive and adopt the Directors' Report and Financial Statements and independent auditor's report thereon.

 

6,219,672

99.95%

2,913

0.05%

347

0.01

6,222,585

2

To receive and adopt the Directors' Remuneration Report

 

6,202,208

99.77%

14,203

0.23%

6,522

0.10

6,216,411

3

To approve the Remuneration Policy

 

6,196,053

 

99.77%

14,078

0.23%

12,802

0.21

6,210,131

4

To re-elect Karen Brade

 

6,215,747

99.92%

5,115

0.08%

2,070

0.03

6,220,862

5

To re-elect Claire Boyle

 

6,212,073

99.87%

8,380

0.13%

2,479

0.04

6,220,453

6

To re-elect Sam Dean

 

6,208,579

99.80%

12,224

0.20%

2,129

0.03

6,220,803

7

To re-elect Sir David Warren

 

6,214,338

99.95%

2,816

0.05%

5,778

0.09

6,217,154

8

To appoint Johnston Carmichael LLP as independent auditor

 

6,210,381

100.00%

198

0.00%

12,353

0.20

6,210,579

9

To authorise the Directors to agree the remuneration of the independent auditor

 

6,221,639

100.00%

198

0.00%

1,095

0.02

6,221,837

10

To authorise the Directors of the Company to allot shares

 

6,117,172

 

 

98.33%

103,916

1.67%

1,844

0.03

6,221,088

11

To approve the disapplication of pre-emption rights

 

6,115,348

98.30%

105,804

1.70%

1,780

0.03

6,221,152

12

To authorise the Company to purchase own shares

 

6,218,168

99.97%

1,731

0.03%

3,033

0.05

6,219,899

 

The ordinary shares will be disabled for settlement in CREST from the close of business on 5 October 2023, trading will be suspended from 7.30am on 6 October 2023 and the ordinary shares will be suspended from listing at 7.30 a.m. on 10 October 2023.

 

The full text of the special and ordinary resolutions can be found in the notice of First General Meeting contained in the Circular. The Circular is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at abrdnjapan.co.uk/en-gb.

 

Pre-liquidation interim dividend

 

As announced on 1 September 2023, a pre-liquidation interim dividend of 3.0 pence per ordinary share will be paid on 29 September 2023 to Shareholders on the register on 15 September 2023.

 

Defined terms used in this announcement have the meanings given in the Circular unless the context otherwise requires.

 

Enquiries

 

abrdn Japan

Karen Brade

E: abrdnjapan@shorecap.co.uk

Shore Capital

 

Robert Finlay/Rose Ramsden/Angus Murphy (Corporate Advisory)

Fiona Conroy (Corporate Broking)

T: 020 7408 4090

 

abrdn Holly Kidd (Company Secretary) T: +44 131 372 2200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUWUNROUUKUAR
Date   Source Headline
5th May 20231:12 pmRNSNet Asset Value(s)
4th May 202312:36 pmRNSNet Asset Value(s)
3rd May 202312:44 pmRNSNet Asset Value(s)
2nd May 20234:05 pmRNSGearing disclosure
28th Apr 20231:00 pmRNSNet Asset Value(s)
27th Apr 20231:17 pmRNSNet Asset Value(s)
26th Apr 20231:12 pmRNSNet Asset Value(s)
25th Apr 202312:45 pmRNSNet Asset Value(s)
24th Apr 20232:26 pmRNSGearing disclosure
24th Apr 202312:19 pmRNSNet Asset Value(s)
21st Apr 202312:58 pmRNSNet Asset Value(s)
20th Apr 202312:37 pmRNSNet Asset Value(s)
19th Apr 202312:02 pmRNSNet Asset Value(s)
18th Apr 202312:40 pmRNSPortfolio disclosure
18th Apr 202312:02 pmRNSNet Asset Value(s)
17th Apr 20235:04 pmRNSGearing disclosure
17th Apr 20231:02 pmRNSNet Asset Value(s)
14th Apr 20231:01 pmRNSNet Asset Value(s)
13th Apr 202312:19 pmRNSNet Asset Value(s)
12th Apr 20231:33 pmRNSNet Asset Value(s)
11th Apr 20233:45 pmRNSGearing disclosure
11th Apr 202312:53 pmRNSNet Asset Value(s)
6th Apr 20234:37 pmRNSMonth End Net Asset Value(s)
6th Apr 202312:45 pmRNSNet Asset Value(s)
5th Apr 20233:07 pmRNSQuarterly disclosure
5th Apr 20231:02 pmRNSNet Asset Value(s)
4th Apr 202312:44 pmRNSNet Asset Value(s)
4th Apr 202310:26 amRNSGearing disclosure
31st Mar 202312:56 pmRNSNet Asset Value(s)
30th Mar 202312:41 pmRNSNet Asset Value(s)
29th Mar 202312:48 pmRNSNet Asset Value(s)
28th Mar 202312:58 pmRNSNet Asset Value(s)
28th Mar 20239:50 amRNSGearing disclosure
27th Mar 202312:49 pmRNSNet Asset Value(s)
24th Mar 202312:11 pmRNSNet Asset Value(s)
23rd Mar 202312:52 pmRNSNet Asset Value(s)
22nd Mar 20231:23 pmRNSNet Asset Value(s)
21st Mar 202312:24 pmRNSNet Asset Value(s)
20th Mar 20232:16 pmRNSGearing Disclosure
20th Mar 202312:33 pmRNSNet Asset Value(s)
17th Mar 20231:08 pmRNSNet Asset Value(s)
16th Mar 20231:20 pmRNSNet Asset Value(s)
15th Mar 202312:06 pmRNSNet Asset Value(s)
14th Mar 202311:46 amRNSNet Asset Value(s)
13th Mar 20232:34 pmRNSGearing disclosure
13th Mar 202311:47 amRNSNet Asset Value(s)
10th Mar 20232:33 pmRNSPortfolio disclosure
10th Mar 202312:36 pmRNSNet Asset Value(s)
9th Mar 202312:31 pmRNSNet Asset Value(s)
8th Mar 202311:40 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.